Skip to main content
. Author manuscript; available in PMC: 2014 Oct 2.
Published in final edited form as: J Cancer Ther. 2013 Jun 1;4(4):898–906. doi: 10.4236/jct.2013.44101

Figure 1.

Figure 1

Evaluation of BC and HME cell lines for CXCR4 expression status by WB analysis. (a) The CXCR4 expression status of MDA-MB231, MDA-MB468, MCF7, DU4475, and HME cells was determined. WB analysis confirmed a lack of expression of CXCR4 in HME (lane 1) and MDA-MB468 (lane 2) cells and the presence of CXCR4 in MDA-MB231 (lane 3), MCF7 (lane 4), and DU4475 (lane 5) cells; (b) Densitometry analysis of WBs showed barely detectable expression of CXCR4 in HME (lane 1) and MDA-MB468 (lane 2) cells but higher expression of CXCR4 in MDA-MB231 (lane 3), MCF7 (lane 4), and DU4475 (lane 5) cells.